RT3-GLP Triple Agonist
A long-acting triple receptor agonist that activates the GLP-1, GIP, and glucagon receptors, designed to study how simultaneous incretin and glucagon pathway stimulation influences metabolism, appetite regulation, and energy balance.

Research Focus

• Mechanisms of glucose control, insulin secretion, and metabolic adaptation.
• Regulation of appetite, fat oxidation, and body composition.
• Coordination between pancreatic, hepatic, and central nervous system signaling.
• Comparison of triple vs. dual-pathway metabolic effects.
• Investigation into obesity, insulin resistance, and cardio-metabolic function.

Mechanisms Under Study

• Combined activation of GLP-1, GIP, and glucagon receptors.
• Integration of hormonal feedback loops governing nutrient sensing and energy use.
• Enhancement of lipid metabolism and lean mass preservation under metabolic stress.

Product Information

• Supplied as a lyophilized sterile powder.
• Third-party verified for purity, molecular identity, and composition.
• For laboratory research use only, not for human or animal use.

CAS Number: 2381089-83-2
Chemical Formula: C₂₅₈H₃₉₃N₆₁O₇₆
Molecular Weight: 5858.39 g/mol
Peptide Type: Tri-agonist (GLP-1, GIP, and Glucagon receptor agonist)
Sequence Type: Proprietary analog of native incretin hormones
Synonyms: LY3437943, Triple Incretin Receptor Agonist
Form: Lyophilized powder
Appearance: White to off-white solid